Login / Signup

Multicenter Population Pharmacokinetics and Exposure-Efficacy Analysis of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.

Peile WangHui LiShanshan ChenHan XingJing YangGuojun ZhangXiaojian Zhang
Published in: Clinical pharmacokinetics (2023)
, as the standard dose (1800 mg/day).
Keyphrases
  • idiopathic pulmonary fibrosis
  • interstitial lung disease
  • cross sectional
  • double blind